Prostate cancer is the most common cancer among American men. Due to prostate-specific antigen screening and early detection, many men with prostate cancer are diagnosed early, when the cancer is still contained within the prostate.
For most men diagnosed with prostate cancer, many management options exist, including surgery, radiation or active surveillance. The decision as to which treatment method is optimal involves many factors, and the purpose of a consultation is to comprehensively review the options. Our prostate cancer specialists are very experienced in the treatment of prostate cancer, having performed more than 4,000 robotic prostatectomies while also having a busy active surveillance program, and non-surgical treatment options, for men electing this approach. We are the #1 program in robotic prostatectomies in Illinois and #5 in the U.S. in terms of volumes. Outcomes are meticulously tracked and collected, for clinical improvements and research, and are among the best in the nation.
Our patients benefit from our productive and collaborative multidisciplinary relationship with other prostate cancer experts at the University. Our specialists in radiation oncology provide state-of-the-art radiation treatment and lead numerous clinical trials investigating innovative treatments. We also work closely with the Department of Radiology and its internationally known experts in MRI of the prostate. Numerous colleagues in medical oncology focus on the care of men with advanced prostate cancer, have access and experience with many therapeutics not available elsewhere and have numerous clinical trials investigating novel agents and combinations.